At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 202 enrolled
Drug / intervention
Clindamycindrug
Likely dose
Clindamycin 2700mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Clinical Trial Between Clindamycin Once and Thrice a Day in Septic Abortion.
In Brief
A Phase 4 clinical trial evaluating Clindamycin for Septic Abortion. Completed, enrolled 202 participants across 1 site.
Detailed Summary
Septic abortion is a serious condition. Women with septic abortion are treated with clindamycin plus gentamicin using divided doses, i.e., thrice a day. The objective of this study is to compare the rates of cure between once or thrice a day use of clindamycin with gentamicin in cases of septic abortion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Abortion
CountriesBrazil
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartDec 2014
Primary CompletionDec 2023
TodayJul 2026
First PostedDec 5, 2014
Enrollment StartDec 17, 2014
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 9.0 yearsPosted 11.6 years ago
Interventions
Clindamycindrug
Use of Clindamycin 2700mg+gentamycin 240mg+ 250ml sterile saline solution i.v. once a day